Biochips Market is expected to reach US$ 80.08 Billion at a CAGR of 18.2% during the forecast period 2029. Biochip is a miniaturized medical device used in molecular laboratories to carry out various biochemical reactions simultaneously. It can rapidly screen many biological analytes for an array of applications like disease diagnosis and detection of hazardous biological agents in a system. It is designed based on microarray and microfluidic technologies, among which digital micro-fluid biochip is highly efficient, and has increased significant popularity in the biochemical field. The report covers all the trends and technologies playing a major role in the growth of the biochips market over the forecast period. It highlights the drivers, restraints, and opportunities expected to influence market growth during 2023-2029. The market for biochips is the increased government funding and R&D investments in the biotech industry.To know about the Research Methodology :- Request Free Sample Report Private organizations along with the governments of many economies have increasingly become aware of the several benefits of biotechnology. About this, all these bodies are highly involved in the investments in the biotechnology sector. Such as the event “BioAsia 2017” hosted by Telangana government (India) has raised an investment worth US$ xx Mn for developing the biotechnology techniques. Lack of proper knowledge about biochip technology is a prominent restraint lowering the market demand for biochip products. The irregularities arriving in healthcare coverage around the world are also more expected to challenge the growth of biochips market globally. Variable cost and adoption of biochip technologies are likely to affect the personalization of medicine, eventually lowering the revenues of the market for biochips. DNA chips segment accounted for the largest xx% share of revenue, as a result of high spending on research about genomics and next-generation sequencing along with growing demand for detection and diagnosis of genetic disorders. Progress in the development of protein microarrays coupled with emerging classes of tissue- and cell-based biochips for various applications are factors anticipated to drive demand for biochips. North America dominates the market for biochips because of the large number of the ageing population and broad technical applications of biochips. The U.S demand for biochip products & services will grow nearly xx% annually through 2022. Growth will be led by uses in drug discovery and epidemiological research, with protein characterization and analysis provided that the expanding technologies. The report gives a competitive analysis of the individual standing of the companies against the global landscape of the biochip industry. The forecast also provides the estimated trends in demand for the biochips market and their impact on the sizes of these companies to help the reader curate profitable business strategies. In Sept 2017, Illumina, Inc. The company announced the acquisition of the GenoLogics Life Science Software, Inc. This acquisition is expected to provide and expand the company’s innovative and informatics solutions for life science organizations, so provide a revenue-generating growth to the market. Biochips market report covers a recent developments like In 2017, Affymetrix and Cytox, an innovative developer of assesses for risk assessment and prediction of dementia, formed a strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease risk assessment. This partnership helped the company extend it's proposing to the dementia research market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Biochips Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Global Biochips Market.
Biochips Market Scope: Inquire before buying
Global Biochips Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 24.84 Bn. Forecast Period 2023 to 2029 CAGR: 18.2% Market Size in 2029: US $ 80.08 Bn. Segments Covered: by Product DNA Chip Protein Chip Lab-on-a-chip Others by Application Drug Discovery & Development Disease Diagnostics Genomics Proteomics Agriculture Others by End User Biotechnology & Pharmaceutical Companies Hospitals & Diagnostics Centers Academic & Research Institutes Others Biochips Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Biochips Market Key Players are:
1. Abbott Laboratories 2. Agilent Technologies, Inc. 3. Perkinelmer, Inc. 4. Fluidigm Corporation 5. Illumina, Inc. 6. GE Healthcare 7. Bio-Rad Laboratories Inc. 8. Cepheid Inc. 9. Thermo Fisher Scientific, Inc. 10. Roche Diagnostics 11. Merck GmbH 12. Randox Laboratories Limited 13. Thermo Fisher Scientific, Inc.Frequently Asked Questions:
1. Which region has the largest share in Global Biochips Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Biochips Market? Ans: The Global Biochips Market is growing at a CAGR of 18.2% during forecasting period 2023-2029. 3. What is scope of the Global Biochips market report? Ans: Global Biochips Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Biochips market? Ans: The important key players in the Global Biochips Market are – Abbott Laboratories, Agilent Technologies, Inc., Perkinelmer, Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare, Bio-Rad Laboratories Inc., Cepheid Inc., Thermo Fisher Scientific, Inc., Roche Diagnostics, Merck GmbH, Randox Laboratories Limited, Thermo Fisher Scientific, and Inc. 5. What is the study period of this market? Ans: The Global Biochips Market is studied from 2022 to 2029.
1. Biochips Market: Research Methodology 2. Biochips Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Biochips Market: Dynamics 3.1. Biochips Market Trends by Region 3.1.1. North America Biochips Market Trends 3.1.2. Europe Biochips Market Trends 3.1.3. Asia Pacific Biochips Market Trends 3.1.4. Middle East and Africa Biochips Market Trends 3.1.5. South America Biochips Market Trends 3.2. Biochips Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Biochips Market Drivers 3.2.1.2. North America Biochips Market Restraints 3.2.1.3. North America Biochips Market Opportunities 3.2.1.4. North America Biochips Market Challenges 3.2.2. Europe 3.2.2.1. Europe Biochips Market Drivers 3.2.2.2. Europe Biochips Market Restraints 3.2.2.3. Europe Biochips Market Opportunities 3.2.2.4. Europe Biochips Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Biochips Market Drivers 3.2.3.2. Asia Pacific Biochips Market Restraints 3.2.3.3. Asia Pacific Biochips Market Opportunities 3.2.3.4. Asia Pacific Biochips Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Biochips Market Drivers 3.2.4.2. Middle East and Africa Biochips Market Restraints 3.2.4.3. Middle East and Africa Biochips Market Opportunities 3.2.4.4. Middle East and Africa Biochips Market Challenges 3.2.5. South America 3.2.5.1. South America Biochips Market Drivers 3.2.5.2. South America Biochips Market Restraints 3.2.5.3. South America Biochips Market Opportunities 3.2.5.4. South America Biochips Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Application Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Biochips Market 3.8. Analysis of Government Schemes and Initiatives For Biochips Market 3.9. The Global Pandemic Impact on Biochips Market 3.10. Microfluidic Integration for Enhanced Precision 3.11. Biosensor Technologies for Real-time Monitoring 3.12. 3D Biochips for Cellular Interaction Studies 4. Biochips Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Biochips Market Size and Forecast, by Product (2023-2030) 4.1.1. DNA Chip 4.1.2. Protein Chip 4.1.3. Lab-on-a-chip 4.1.4. Others 4.2. Biochips Market Size and Forecast, by Application (2023-2030) 4.2.1. Drug Discovery & Development 4.2.2. Disease Diagnostics 4.2.3. Genomics 4.2.4. Proteomics 4.2.5. Agriculture 4.2.6. Others 4.3. Biochips Market Size and Forecast, by End User (2023-2030) 4.3.1. Biotechnology & Pharmaceutical Companies 4.3.2. Hospitals & Diagnostics Centers 4.3.3. Academic & Research Institutes 4.3.4. Others 4.4. Biochips Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Biochips Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Biochips Market Size and Forecast, by Product (2023-2030) 5.1.1. DNA Chip 5.1.2. Protein Chip 5.1.3. Lab-on-a-chip 5.1.4. Others 5.2. North America Biochips Market Size and Forecast, by Application (2023-2030) 5.2.1. Drug Discovery & Development 5.2.2. Disease Diagnostics 5.2.3. Genomics 5.2.4. Proteomics 5.2.5. Agriculture 5.2.6. Others 5.3. North America Biochips Market Size and Forecast, by End User (2023-2030) 5.3.1. Biotechnology & Pharmaceutical Companies 5.3.2. Hospitals & Diagnostics Centers 5.3.3. Academic & Research Institutes 5.3.4. Others 5.4. North America Biochips Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Biochips Market Size and Forecast, by Product (2023-2030) 5.4.1.1.1. DNA Chip 5.4.1.1.2. Protein Chip 5.4.1.1.3. Lab-on-a-chip 5.4.1.1.4. Others 5.4.1.2. United States Biochips Market Size and Forecast, by Application (2023-2030) 5.4.1.2.1. Drug Discovery & Development 5.4.1.2.2. Disease Diagnostics 5.4.1.2.3. Genomics 5.4.1.2.4. Proteomics 5.4.1.2.5. Agriculture 5.4.1.2.6. Others 5.4.1.3. United States Biochips Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Biotechnology & Pharmaceutical Companies 5.4.1.3.2. Hospitals & Diagnostics Centers 5.4.1.3.3. Academic & Research Institutes 5.4.1.3.4. Others 5.4.2. Canada 5.4.2.1. Canada Biochips Market Size and Forecast, by Product (2023-2030) 5.4.2.1.1. DNA Chip 5.4.2.1.2. Protein Chip 5.4.2.1.3. Lab-on-a-chip 5.4.2.1.4. Others 5.4.2.2. Canada Biochips Market Size and Forecast, by Application (2023-2030) 5.4.2.2.1. Drug Discovery & Development 5.4.2.2.2. Disease Diagnostics 5.4.2.2.3. Genomics 5.4.2.2.4. Proteomics 5.4.2.2.5. Agriculture 5.4.2.2.6. Others 5.4.2.3. Canada Biochips Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Biotechnology & Pharmaceutical Companies 5.4.2.3.2. Hospitals & Diagnostics Centers 5.4.2.3.3. Academic & Research Institutes 5.4.2.3.4. Others 5.4.3. Mexico 5.4.3.1. Mexico Biochips Market Size and Forecast, by Product (2023-2030) 5.4.3.1.1. DNA Chip 5.4.3.1.2. Protein Chip 5.4.3.1.3. Lab-on-a-chip 5.4.3.1.4. Others 5.4.3.2. Mexico Biochips Market Size and Forecast, by Application (2023-2030) 5.4.3.2.1. Drug Discovery & Development 5.4.3.2.2. Disease Diagnostics 5.4.3.2.3. Genomics 5.4.3.2.4. Proteomics 5.4.3.2.5. Agriculture 5.4.3.2.6. Others 5.4.3.3. Mexico Biochips Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Biotechnology & Pharmaceutical Companies 5.4.3.3.2. Hospitals & Diagnostics Centers 5.4.3.3.3. Academic & Research Institutes 5.4.3.3.4. Others 6. Europe Biochips Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Biochips Market Size and Forecast, by Product (2023-2030) 6.2. Europe Biochips Market Size and Forecast, by Application (2023-2030) 6.3. Europe Biochips Market Size and Forecast, by End User (2023-2030) 6.4. Europe Biochips Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Biochips Market Size and Forecast, by Product (2023-2030) 6.4.1.2. United Kingdom Biochips Market Size and Forecast, by Application (2023-2030) 6.4.1.3. United Kingdom Biochips Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Biochips Market Size and Forecast, by Product (2023-2030) 6.4.2.2. France Biochips Market Size and Forecast, by Application (2023-2030) 6.4.2.3. France Biochips Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Biochips Market Size and Forecast, by Product (2023-2030) 6.4.3.2. Germany Biochips Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Germany Biochips Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Biochips Market Size and Forecast, by Product (2023-2030) 6.4.4.2. Italy Biochips Market Size and Forecast, by Application (2023-2030) 6.4.4.3. Italy Biochips Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Biochips Market Size and Forecast, by Product (2023-2030) 6.4.5.2. Spain Biochips Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Spain Biochips Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Biochips Market Size and Forecast, by Product (2023-2030) 6.4.6.2. Sweden Biochips Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Sweden Biochips Market Size and Forecast, by End User (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Biochips Market Size and Forecast, by Product (2023-2030) 6.4.7.2. Austria Biochips Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Austria Biochips Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Biochips Market Size and Forecast, by Product (2023-2030) 6.4.8.2. Rest of Europe Biochips Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Rest of Europe Biochips Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Biochips Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Biochips Market Size and Forecast, by Product (2023-2030) 7.2. Asia Pacific Biochips Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Biochips Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Biochips Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Biochips Market Size and Forecast, by Product (2023-2030) 7.4.1.2. China Biochips Market Size and Forecast, by Application (2023-2030) 7.4.1.3. China Biochips Market Size and Forecast, by End User (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Biochips Market Size and Forecast, by Product (2023-2030) 7.4.2.2. S Korea Biochips Market Size and Forecast, by Application (2023-2030) 7.4.2.3. S Korea Biochips Market Size and Forecast, by End User (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Biochips Market Size and Forecast, by Product (2023-2030) 7.4.3.2. Japan Biochips Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Japan Biochips Market Size and Forecast, by End User (2023-2030) 7.4.4. India 7.4.4.1. India Biochips Market Size and Forecast, by Product (2023-2030) 7.4.4.2. India Biochips Market Size and Forecast, by Application (2023-2030) 7.4.4.3. India Biochips Market Size and Forecast, by End User (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Biochips Market Size and Forecast, by Product (2023-2030) 7.4.5.2. Australia Biochips Market Size and Forecast, by Application (2023-2030) 7.4.5.3. Australia Biochips Market Size and Forecast, by End User (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Biochips Market Size and Forecast, by Product (2023-2030) 7.4.6.2. Indonesia Biochips Market Size and Forecast, by Application (2023-2030) 7.4.6.3. Indonesia Biochips Market Size and Forecast, by End User (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Biochips Market Size and Forecast, by Product (2023-2030) 7.4.7.2. Malaysia Biochips Market Size and Forecast, by Application (2023-2030) 7.4.7.3. Malaysia Biochips Market Size and Forecast, by End User (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Biochips Market Size and Forecast, by Product (2023-2030) 7.4.8.2. Vietnam Biochips Market Size and Forecast, by Application (2023-2030) 7.4.8.3. Vietnam Biochips Market Size and Forecast, by End User (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Biochips Market Size and Forecast, by Product (2023-2030) 7.4.9.2. Taiwan Biochips Market Size and Forecast, by Application (2023-2030) 7.4.9.3. Taiwan Biochips Market Size and Forecast, by End User (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Biochips Market Size and Forecast, by Product (2023-2030) 7.4.10.2. Rest of Asia Pacific Biochips Market Size and Forecast, by Application (2023-2030) 7.4.10.3. Rest of Asia Pacific Biochips Market Size and Forecast, by End User (2023-2030) 8. Middle East and Africa Biochips Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 8.1. Middle East and Africa Biochips Market Size and Forecast, by Product (2023-2030) 8.2. Middle East and Africa Biochips Market Size and Forecast, by Application (2023-2030) 8.3. Middle East and Africa Biochips Market Size and Forecast, by End User (2023-2030) 8.4. Middle East and Africa Biochips Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Biochips Market Size and Forecast, by Product (2023-2030) 8.4.1.2. South Africa Biochips Market Size and Forecast, by Application (2023-2030) 8.4.1.3. South Africa Biochips Market Size and Forecast, by End User (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Biochips Market Size and Forecast, by Product (2023-2030) 8.4.2.2. GCC Biochips Market Size and Forecast, by Application (2023-2030) 8.4.2.3. GCC Biochips Market Size and Forecast, by End User (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Biochips Market Size and Forecast, by Product (2023-2030) 8.4.3.2. Nigeria Biochips Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Nigeria Biochips Market Size and Forecast, by End User (2023-2030) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Biochips Market Size and Forecast, by Product (2023-2030) 8.4.4.2. Rest of ME&A Biochips Market Size and Forecast, by Application (2023-2030) 8.4.4.3. Rest of ME&A Biochips Market Size and Forecast, by End User (2023-2030) 9. South America Biochips Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 9.1. South America Biochips Market Size and Forecast, by Product (2023-2030) 9.2. South America Biochips Market Size and Forecast, by Application (2023-2030) 9.3. South America Biochips Market Size and Forecast, by End User (2023-2030) 9.4. South America Biochips Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Biochips Market Size and Forecast, by Product (2023-2030) 9.4.1.2. Brazil Biochips Market Size and Forecast, by Application (2023-2030) 9.4.1.3. Brazil Biochips Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Biochips Market Size and Forecast, by Product (2023-2030) 9.4.2.2. Argentina Biochips Market Size and Forecast, by Application (2023-2030) 9.4.2.3. Argentina Biochips Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Biochips Market Size and Forecast, by Product (2023-2030) 9.4.3.2. Rest Of South America Biochips Market Size and Forecast, by Application (2023-2030) 9.4.3.3. Rest Of South America Biochips Market Size and Forecast, by End User (2023-2030) 10. Global Biochips Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2023) 10.3.5. Company Locations 10.4. Leading Biochips Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Abbott Laboratories 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Recent Developments 11.2. Agilent Technologies, Inc. 11.3. Perkinelmer, Inc. 11.4. Fluidigm Corporation 11.5. Illumina, Inc. 11.6. GE Healthcare 11.7. Bio-Rad Laboratories Inc. 11.8. Cepheid Inc. 11.9. Thermo Fisher Scientific, Inc. 11.10. Roche Diagnostics 11.11. Merck GmbH 11.12. Randox Laboratories Limited 11.13. Thermo Fisher Scientific, Inc. 12. Key Findings 13. Industry Recommendations